1 – 30 of 30
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Exceptions and limitations (27 UPCA)
2023) p.109-128(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Creative Machines, Orphan Inventions: AI and the concept of inventor at the EPO
2022) p.159-180(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Balancing innovation, ‘ordre public’ and morality in human germline editing : A call for more nuanced approaches in patent law
(
- Contribution to journal › Article
- 2021
-
Mark
Big Science, Big Data, Big Innovation? : ERIC Policies on IP, Data and Technology Transfer
2021) p.65-106(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
- 2020
-
Mark
Patents, Morality and Biomedical Innovation in Europe : Historical overview, current debates on stem cells, gene editing and AI, and de lege ferenda reflections
2020) p.243-267(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Cutting Edges and Weaving Threads in the Gene Editing (Я)evolution : Reconciling scientific progress with Legal, Ethical, & Social concerns
(
- Contribution to journal › Article
- 2017
-
Mark
Patenting Nanomedicine in Europe : Applying the 'medical methods exception' to emerging technologies
2017)(
- Book/Report › Book
- 2015
-
Mark
The Relationship between Copyright and Patent Protection in European Union Law
2015) p.231-251(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Patentability of methods of human enhancement
(
- Contribution to journal › Article
- 2014
-
Mark
The ”opt out” and “opt in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios
(
- Contribution to journal › Article
- 2013
-
Mark
Nanotechnology, Human Rights, Patent law and the Global South: a brief overview
2013) p.313-332(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2012
-
Mark
Economic Justification of Patents and Exceptions to Patentability
(
- Contribution to journal › Article
-
Mark
What intent, whose intent and to what extent?: The Knowledge requirement in indirect patent infringement
(
- Contribution to journal › Article
-
Mark
The industrial application requirement for biotech inventions in light of recent EPO & UK case law:: A plausible "hunting license"?"
(
- Contribution to journal › Article
-
Mark
The US Supreme Court in Mayo v Prometheus - taking the fire from or to biotechnology and personalized medicine?
(
- Contribution to journal › Article
- 2011
-
Mark
US Patent Eligibility in the Wake of Bilski v Kappos: "Business as Usual" in an Age of New Technologies?
(
- Contribution to journal › Article
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part I
(
- Contribution to journal › Article
-
Mark
Contribution to case law summaries and comments: Tri-lingual
2011)(
- Book/Report › Book
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO – Part I
(
- Contribution to journal › Article
- 2010
-
Mark
Nanotechnology patents in Europe and the exception from patent for methods for treatment and diagnostic methods
(
- Contribution to journal › Article
- 2009
-
Mark
“Restoring the balance: The patentability of DNA-related technology in the US and Europe”
2009) Scholarship speech prepared for the AWAPATENT Foundation for the Promotion of Scientific Research in the Area of Intellectual Property Rights. p.1-10(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2008
-
Mark
Standing in the shadows of Brüstle: ordre public & the patentability of human embryonic stem cell technology in Germany and at the EPO
2008) In Historielärarnas Förenings Årsskrift(
- Contribution to journal › Article
-
Mark
Is In re Deuel still the law of the land? The US examination of nonobviousness after KSR v. Teleflex with special emphasis on DNA related inventions
2008) In Historielärarnas Förenings Årsskrift(
- Contribution to journal › Article
-
Mark
The US Examination of Nonobviousness after KSR vs. Teleflex with Special Emphasis on DNA-Related Inventions
(
- Contribution to journal › Article
-
Mark
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar?--Del 1:--Om nyare utvecklingar kring kravet på’industrial application’och’utility’för gen-och proteinrelaterade uppfinningar i USA och Europa
(
- Contribution to journal › Article
-
Mark
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
(
- Contribution to journal › Article
- 2007
-
Mark
Obesvarade frågor rörande patent på datorrelaterade uppfinningar och affärsmetoder?: Reflektioner kring Alain Pompidous brev till Lord Justice Jacob
(
- Contribution to journal › Article
- 2005
-
Mark
Patenting human DNA sequences in Europe and the US - A comparative analysis of patentability requirements for nucleic acid sequences with special emphasis on novelty and inventive step
2005)(
- Thesis › Licentiate thesis
-
Mark
Patenting Human DNA sequences in Europe and the U.S.: A comparative analysis of patentability requirements for nucleic acid sequences
2005)(
- Book/Report › Book